Urinary Incontinence and Pelvic Organ Prolapse in Women

Overview

Journal Dtsch Arztebl Int

Specialties General Medicine
Public Health

Date 2023 Jan 17

PMID 36647585

Authors

Ralf Tunn

Kaven Baessler

Stephanie Knupfer

Christian Hampel

Affiliations

Soon will be listed here.

Abstract

Background: Pelvic floor disorders are common, especially in pregnancy and after delivery, in the postmenopausal period, and old age, and they can significantly impact on the patient's quality of life.

Methods: This narrative review is based on publications retrieved by a selective search of the literature, with special consideration to original articles and AWMF guidelines.

Results: Pelvic floor physiotherapy (evidence level [EL] 1), the use of pessaries (EL2), and local estrogen therapy can help alleviate stress/urge urinary incontinence and other symptoms of urogenital prolapse. Physiotherapy can reduce urinary incontinence by 62% during pregnancy and by 29% 3-6 months post partum. Anticholinergic and β-sympathomimetic drugs are indicated for the treatment of an overactive bladder with or without urinary urge incontinence (EL1). For patients with stress urinary incontinence, selective serotonin-noradrenaline reuptake inhibitors can be prescribed (EL1). The tension-free tape is the current standard of surgical treatment (EL1); in an observational follow-up study, 87.2% of patients were satisfied with the outcome 17 years after surgery. Fascial reconstruction techniques are indicated for the treatment of primary pelvic organ prolapse, and mesh-based surgical procedures for recurrences and severe prolapse (EL1).

Conclusion: Urogynecological symptoms should be specifically asked about by physicians of all relevant specialties; if present, they should be treated conservatively at first. Structured surgical techniques with and without mesh are available for the treatment of urinary incontinence and pelvic organ prolapse. Preventive measures against pelvic floor dysfunction should be offered during pregnancy and post partum.

Citing Articles

Best evidence for rehabilitation management of urinary incontinence in patients with bladder cancer following orthotopic neobladder reconstruction.

Xu M, Chen S, Liu X, Luo Y, Wang D, Lu H Asia Pac J Oncol Nurs. 2025; 12:100647.

PMID: 39896758 PMC: 11782885. DOI: 10.1016/j.apjon.2024.100647.

The Efficacy of Pelvic Floor Rehabilitation in the Treatment of Urinary Incontinence in Female Athletes: A Systematic Review.

Demeco A, Bartocci G, Astore N, Vignali B, Salerno A, Palermi S Sports (Basel). 2024; 12(12).

PMID: 39728878 PMC: 11679242. DOI: 10.3390/sports12120338.

Prevalence and Associated Risk Factors of Urinary Incontinence in Sexually Active Women in Ecuador.

Zeas-Puga A, Mendez-Sacta V, Vega Crespo B, Samijn B, Herve F, Martinez-Merinero P Healthcare (Basel). 2024; 12(22).

PMID: 39595493 PMC: 11593529. DOI: 10.3390/healthcare12222296.

Mechanical Stress-Oxidative Stress Axis: Biological Basis in the Vaginal Wall and Pelvic Floor Muscles of Rats with Simulated Birth Injury.

Wang Q, Wu X, Wang S, Xie B, Sun X, Wang J Int Urogynecol J. 2024; 35(11):2141-2152.

PMID: 39373911 DOI: 10.1007/s00192-024-05943-9.

The International Consultation on Incontinence Questionnaire Short Form as a Substitute for 1-Hour Pad Weight Testing in the Evaluation of Urinary Incontinence in Patients With Pelvic Organ Prolapse Undergoing Surgery.

Kuroda K, Hamamoto K, Kawamura K, Masunaga A, Kobayashi H, Horiguchi A Int Neurourol J. 2024; 28(3):215-224.

PMID: 39363412 PMC: 11450242. DOI: 10.5213/inj.2448234.117.

References

Holdo B, Verelst M, Svenningsen R, Milsom I, Skjeldestad F . Long-term clinical outcomes with the retropubic tension-free vaginal tape (TVT) procedure compared to Burch colposuspension for correcting stress urinary incontinence (SUI). Int Urogynecol J. 2017; 28(11):1739-1746. DOI: 10.1007/s00192-017-3345-0. View

Ahmed A, Abdellatif A, El-Helaly H, Tagreda I, El-Feky M, Agha M . Concomitant transobturator tape and anterior colporrhaphy versus transobturator subvesical mesh for cystocele-associated stress urinary incontinence. Int Urogynecol J. 2019; 31(8):1633-1640. DOI: 10.1007/s00192-019-04068-8. View

Nilsson C, Palva K, Aarnio R, Morcos E, Falconer C . Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J. 2013; 24(8):1265-9. DOI: 10.1007/s00192-013-2090-2. View

Gyhagen M, Bullarbo M, Nielsen T, Milsom I . Prevalence and risk factors for pelvic organ prolapse 20 years after childbirth: a national cohort study in singleton primiparae after vaginal or caesarean delivery. BJOG. 2012; 120(2):152-160. DOI: 10.1111/1471-0528.12020. View

Hampel C, Neisius A, Thomas C, Thuroff J, Roos F . [Vesicovaginal fistula. Incidence, etiology and phenomenology in Germany]. Urologe A. 2015; 54(3):349-58. DOI: 10.1007/s00120-014-3679-x. View

Chiengthong K, Ruanphoo P, Chatsuwan T, Bunyavejchevin S . Effect of vaginal estrogen in postmenopausal women using vaginal pessary for pelvic organ prolapse treatment: a randomized controlled trial. Int Urogynecol J. 2021; 33(7):1833-1838. DOI: 10.1007/s00192-021-04821-y. View

Boyd S, Subramanian D, Propst K, OSullivan D, Tulikangas P . Pelvic Organ Prolapse Severity and Genital Hiatus Size With Long-Term Pessary Use. Female Pelvic Med Reconstr Surg. 2020; 27(2):e360-e362. DOI: 10.1097/SPV.0000000000000937. View

Chapple C, Dvorak V, Radziszewski P, Van Kerrebroeck P, Wyndaele J, Bosman B . A phase II dose-ranging study of mirabegron in patients with overactive bladder. Int Urogynecol J. 2013; 24(9):1447-58. PMC: 3745617. DOI: 10.1007/s00192-013-2042-x. View

Dogan O, Ellibes Kaya A, Pulatoglu C, Basbug A, Yassa M . A randomized comparison of a single-incision needleless (Contasure-needleless®) mini-sling versus an inside-out transobturator (Contasure-KIM®) mid-urethral sling in women with stress urinary incontinence: 24-month follow-up results. Int Urogynecol J. 2018; 29(9):1387-1395. DOI: 10.1007/s00192-018-3624-4. View

10.

Noe K, Schiermeier S, Alkatout I, Anapolski M . Laparoscopic pectopexy: a prospective, randomized, comparative clinical trial of standard laparoscopic sacral colpocervicopexy with the new laparoscopic pectopexy-postoperative results and intermediate-term follow-up in a pilot study. J Endourol. 2014; 29(2):210-5. PMC: 4313410. DOI: 10.1089/end.2014.0413. View

11.

Bascur-Castillo C, Carrasco-Portino M, Valenzuela-Peters R, Orellana-Gaete L, Viveros-Allende V, Ruiz Cantero M . Effect of conservative treatment of pelvic floor dysfunctions in women: An umbrella review. Int J Gynaecol Obstet. 2022; 159(2):372-391. DOI: 10.1002/ijgo.14172. View

12.

Lucot J, Cosson M, Verdun S, Debodinance P, Bader G, Campagne-Loiseau S . Long-term outcomes of primary cystocele repair by transvaginal mesh surgery versus laparoscopic mesh sacropexy: extended follow up of the PROSPERE multicentre randomised trial. BJOG. 2021; 129(1):127-137. DOI: 10.1111/1471-0528.16847. View

13.

van IJsselmuiden M, van Oudheusden A, Veen J, van de Pol G, Vollebregt A, Radder C . Hysteropexy in the treatment of uterine prolapse stage 2 or higher: laparoscopic sacrohysteropexy versus sacrospinous hysteropexy-a multicentre randomised controlled trial (LAVA trial). BJOG. 2020; 127(10):1284-1293. DOI: 10.1111/1471-0528.16242. View

14.

Mowat A, Maher D, Baessler K, Christmann-Schmid C, Haya N, Maher C . Surgery for women with posterior compartment prolapse. Cochrane Database Syst Rev. 2018; 3:CD012975. PMC: 6494287. DOI: 10.1002/14651858.CD012975. View

15.

Hay-Smith E, Herderschee R, Dumoulin C, Herbison G . Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev. 2011; 12):CD009508. DOI: 10.1002/14651858.CD009508. View

16.

Staskin D, Kay G, Tannenbaum C, Goldman H, Bhashi K, Ling J . Trospium chloride is undetectable in the older human central nervous system. J Am Geriatr Soc. 2010; 58(8):1618-9. DOI: 10.1111/j.1532-5415.2010.02988.x. View

17.

Siegel S, Noblett K, Mangel J, Bennett J, Griebling T, Sutherland S . Five-Year Followup Results of a Prospective, Multicenter Study of Patients with Overactive Bladder Treated with Sacral Neuromodulation. J Urol. 2017; 199(1):229-236. DOI: 10.1016/j.juro.2017.07.010. View

18.

Chapple C, Khullar V, Nitti V, Frankel J, Herschorn S, Kaper M . Efficacy of the β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. Eur Urol. 2014; 67(1):11-14. DOI: 10.1016/j.eururo.2014.06.052. View

19.

Novack G, Lewis R, Vogel R, Sheth N, Swearingen D, Rasmussen S . Randomized, double-masked, placebo-controlled study to assess the ocular safety of mirabegron in healthy volunteers. J Ocul Pharmacol Ther. 2013; 29(7):674-80. DOI: 10.1089/jop.2012.0254. View

20.

Dejene S, Funk M, Pate V, Wu J . Long-Term Outcomes After Midurethral Mesh Sling Surgery for Stress Urinary Incontinence. Female Pelvic Med Reconstr Surg. 2021; 28(4):188-193. PMC: 9169553. DOI: 10.1097/SPV.0000000000001094. View